Adoption of international good manufacturing practices in the Nigerian pharmaceutical industry: promising results from a decade of investment

Collaboration among NAFDAC, local manufacturers, the WHO PQ Team, and other partners enabled successful implementation of these programs, culminating in WHO PQ of Swiss Pharma Nigeria Limited's zinc sulfate dispersible tablets on June 6, 2023 - the first in West Africa. However, significant challenges persist, including insufficient understanding of WHO PQ requirements, inadequate GMP-compliant facilities, and financial constraints. Addressing these issues requires targeted interventions focused on GMP awareness, infrastructure investment, regulatory support, and harnessing Nigeria's potential as a pharmaceutical manufacturing hub.